Pressure-independent effects of pharmacological stimulation of soluble guanylate cyclase on fibrosis in pressure-overloaded rat heart. (Q46020956)

18 December 2017

title

Pressure-independent effects of pharmacological stimulation of soluble guanylate cyclase on fibrosis in pressure-overloaded rat heart. (English)

1 reference

18 December 2017

1 reference

Johannes-Peter Stasch

object named as

Johannes-Peter Stasch

1 reference

18 December 2017

Hiroyuki Masuyama

1 reference

18 December 2017

Toshihiro Tsuruda

1 reference

18 December 2017

Yoko Sekita

1 reference

18 December 2017

Kinta Hatakeyama

1 reference

18 December 2017

Takuroh Imamura

1 reference

18 December 2017

Johji Kato

1 reference

18 December 2017

Yujiro Asada

1 reference

18 December 2017

Kazuo Kitamura

1 reference

18 December 2017

publication date

8 May 2009

1 reference

18 December 2017

published in

Hypertension Research

1 reference

18 December 2017

volume

1 reference

18 December 2017

issue

1 reference

18 December 2017

page(s)

597-603

1 reference

18 December 2017

Diastolic dysfunction in hypertensive hearts: roles of perivascular inflammation and reactive myocardial fibrosis

cites work

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.64

Myocardial fibrosis and diastolic dysfunction in patients with hypertension: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.64

Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.64

Fibrosis and hypertensive heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.64

Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.64

Volume overload results in exaggerated cardiac hypertrophy in the atrial natriuretic peptide knockout mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.64

Natriuretic peptides inhibit DNA synthesis in cardiac fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.64

Brain natriuretic Peptide is produced in cardiac fibroblasts and induces matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.64

Cardiac fibrosis in mice lacking brain natriuretic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.64

Regulation of cardiac fibroblast extracellular matrix production by bradykinin and nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.64

NO-independent regulatory site on soluble guanylate cyclase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.64

Cardiorenal and humoral properties of a novel direct soluble guanylate cyclase stimulator BAY 41-2272 in experimental congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.64

Soluble guanylate cyclase activator reverses acute pulmonary hypertension and augments the pulmonary vasodilator response to inhaled nitric oxide in awake lambs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.64

Functional interplay between angiotensin II and nitric oxide: cyclic GMP as a key mediator

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.64

Inhibition of TGF-beta induced lung fibroblast to myofibroblast conversion by phosphodiesterase inhibiting drugs and activators of soluble guanylyl cyclase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.64

Rapid increase in cardiac adrenomedullin gene expression caused by acute pressure overload: effect of the renin-angiotensin system on gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.64

Prenatal malnutrition-induced changes in blood pressure: dissociation of stress and nonstress responses using radiotelemetry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.64

Augmented diurnal variations of the cardiac renin-angiotensin system in hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.64

Adrenomedullin: A Possible Autocrine or Paracrine Inhibitor of Hypertrophy of Cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.64

Isolation and identification of proangiotensin-12, a possible component of the renin-angiotensin system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.64

Enhancing cGMP in experimental progressive renal fibrosis: soluble guanylate cyclase stimulation vs. phosphodiesterase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.64

NO-independent activation of soluble guanylate cyclase prevents disease progression in rats with 5/6 nephrectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.64

Pressure-independent effects of angiotensin II on hypertensive myocardial fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.64

The progression from hypertension to congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.64

7 January 2021

Hypertensive heart disease

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.64

7 January 2021

Ventricular arrhythmias in hypertensive left ventricular hypertrophy. Relationship to coronary artery disease, left ventricular dysfunction, and myocardial fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.64

7 January 2021

Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.64

7 January 2021

Soluble guanylate cyclase stimulation on cardiovascular remodeling in angiotensin II-induced hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.64

7 January 2021

Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.64

7 January 2021

Antifibrotic effect of adrenomedullin on coronary adventitia in angiotensin II-induced hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.64

7 January 2021

Influence of aortic impedance on the development of pressure-overload left ventricular hypertrophy in rats

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.64

7 January 2021

Tissue Angiotensin-converting enzyme activity plays an important role in pressure overload-induced cardiac fibrosis in rats

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.64

7 January 2021

Angiotensin converting enzyme is the main contributor to angiotensin I-II conversion in the interstitium of the isolated perfused rat heart

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.64

7 January 2021

Glucocorticoid regulation of angiotensin-converting enzyme in primary culture of adult cardiac fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.64

7 January 2021

Upregulation of angiotensin-converting enzyme by vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.64

7 January 2021

Transforming growth factor-beta(1) induces angiotensin-converting enzyme synthesis in rat cardiac fibroblasts during their differentiation to myofibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.64

7 January 2021

Identifiers

DOI

10.1038/HR.2009.64

1 reference

18 December 2017

1 reference

18 December 2017